[1] CHEN W, ZHENG R, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. [2] HAN J, LI E, CHEN L, et al. The CREB coactivator CRTC2 controls hepatic lipid metabolism by regulating SREBP1[J]. Nature, 2015, 524(7564):243-246. [3] STEVEN A, SELIGER B. Control of CREB expression in tumors:from molecular mechanisms and signal transduction pathways to therapeutic target[J]. Oncotarget, 2016, 7(23):35454-35465. [4] DOBROFF A S, WANG H, MELNIKOVA V O, et al. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma[J]. J Biol Chem, 2009, 284(38):26194-26206. [5] YANG X X, MA M, SANG M X, et al. BMI-1 suppression increases the radiosensitivity of oesophageal carcinoma via the PI3K/Akt signaling pathway[J]. Oncol Rep, 2018, 39(2):667-678. [6] SANG M, HULSURKAR M, ZHANG X, et al. GRK3 is a direct target of CREB activation and regulates neuroendocrine differentiation of prostate cancer cells[J]. Oncotarget, 2016, 7(29):45171-45185. [7] CHEN Z, LI J L, LIN S, et al. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth[J]. J Clin Invest, 2016, 126(6):2267-2279. [8] ZHANG Y, ZHENG D, ZHOU T, et al. Androgen deprivation promotes neuroendocrine differentiation and angiogenesis through CREB-EZH2-TSP1 pathway in prostate cancers[J]. Nat Commun, 2018, 9(1):4080. [9] GLOUSHANKOVA N A. Changes in regulation of cell-cell adhesion during tumor transformation[J]. Biochemistry (Mosc), 2008, 73(7):742-750. [10] VOROPAEV H, GIMMELSHEIN VATKIN M, SHNEOR D, et al. Infectious knockdown of CREB and HIF-1 for the treatment of metastatic uveal melanoma[J]. Cancers, 2019, 11(8):1056. [11] CHEN P, LI M M, HAO Q Y, et al. Targeting the overexpressed CREB inhibits esophageal squamous cell carcinoma cell growth[J]. Oncol Rep, 2017, 39(3):1369-1377. |